The board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited announces that, with effect from 9 March 2022: 1. Ms. Ding Yong Ling ("Ms. Ding"), had ceased to be a member of the remuneration committee (the "Remuneration Committee") and nomination committee (the "Nomination Committee") of the Company. Ms. Ding will continue to act as the chairman of the Board and the executive director of the Company; 2. Mr. Tsang Yok Sing, Jasper ("Mr. Tsang"), the independent non-executive director of the Company, had been appointed as the member of the Remuneration Committee. 3. Mr. Zhao Zhong Zhen ("Mr. Zhao"), the independent non-executive director of the Company, had been appointed as the member of the Nomination Committee.

Following the aforementioned changes, the Remuneration Committee and the Nomination Committee both comprise Mr. Tsang, Mr. Zhao, and Mr. Chan Ngai Chi, the independent non-executive directors of the Company.